CN103214489B - 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法 - Google Patents

一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法 Download PDF

Info

Publication number
CN103214489B
CN103214489B CN201310060319.9A CN201310060319A CN103214489B CN 103214489 B CN103214489 B CN 103214489B CN 201310060319 A CN201310060319 A CN 201310060319A CN 103214489 B CN103214489 B CN 103214489B
Authority
CN
China
Prior art keywords
amine
acid
phenyl
nitrae
isosorbide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310060319.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN103214489A (zh
Inventor
周有骏
周峰
李唯
刘嘉
陈莎娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CN201310060319.9A priority Critical patent/CN103214489B/zh
Publication of CN103214489A publication Critical patent/CN103214489A/zh
Application granted granted Critical
Publication of CN103214489B publication Critical patent/CN103214489B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

CN201310060319.9A 2013-02-25 2013-02-25 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法 Expired - Fee Related CN103214489B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310060319.9A CN103214489B (zh) 2013-02-25 2013-02-25 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310060319.9A CN103214489B (zh) 2013-02-25 2013-02-25 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法

Publications (2)

Publication Number Publication Date
CN103214489A CN103214489A (zh) 2013-07-24
CN103214489B true CN103214489B (zh) 2016-10-26

Family

ID=48812697

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310060319.9A Expired - Fee Related CN103214489B (zh) 2013-02-25 2013-02-25 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法

Country Status (1)

Country Link
CN (1) CN103214489B (und)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104788484B (zh) * 2015-04-30 2017-01-11 杭州拜善晟生物科技有限公司 一种2-硝基苯基硼酸的合成方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198743A (zh) * 1995-10-02 1998-11-11 弗·哈夫曼-拉罗切有限公司 作为5HT2c－受体拮抗剂的嘧啶衍生物
WO2003050090A1 (en) * 2001-11-27 2003-06-19 Wyeth Holdings Corporation 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
CN101631464A (zh) * 2006-12-05 2010-01-20 拜耳先灵医药股份有限公司 用于治疗过度增殖疾病和血管发生相关性疾病的2,3-二氢咪唑并[1,2-c]喹唑啉取代衍生物
CN102906094A (zh) * 2010-11-11 2013-01-30 拜耳知识产权有限责任公司 用于治疗过度增殖性病症和与血管发生相关的疾病的氨基醇取代的2,3-二氢咪唑并[1,2-c]喹唑啉衍生物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198743A (zh) * 1995-10-02 1998-11-11 弗·哈夫曼-拉罗切有限公司 作为5HT2c－受体拮抗剂的嘧啶衍生物
WO2003050090A1 (en) * 2001-11-27 2003-06-19 Wyeth Holdings Corporation 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
CN101631464A (zh) * 2006-12-05 2010-01-20 拜耳先灵医药股份有限公司 用于治疗过度增殖疾病和血管发生相关性疾病的2,3-二氢咪唑并[1,2-c]喹唑啉取代衍生物
CN102906094A (zh) * 2010-11-11 2013-01-30 拜耳知识产权有限责任公司 用于治疗过度增殖性病症和与血管发生相关的疾病的氨基醇取代的2,3-二氢咪唑并[1,2-c]喹唑啉衍生物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Concise synthesis and anti-HIV activity of pyrimido[1,2-c][1,3]benzothiazin-6-imines and related tricyclic heterocycles;Mizuhara, Tsukasa 等;《Organic & Biomolecular Chemistry》;20120622;第10卷(第33期);第2649-2658页 *
Rapid Access to Pyrimido[5,4-c]isoquinolines via a Sulfur Monoxide Extrusion Reaction;Renzhong Fu 等;《ORGANIC LETTERS》;20070120;第9卷(第4期);第571-574页 *
Synthesis of 2,4-Diaminoquinazolines and Tricyclic Quinazolines by Cascade Reductive Cyclization of Methyl N-Cyano-2-nitrobenzimidates;Ping Yin 等;《The Journal of Organic Chemistry》;20120127;第77卷(第6期);第6792-6802页 *
具新生血管抑制及血管阻断双重作用的肿瘤血管靶向药物研究进展;周峰 等;《药学进展》;20130115;第37卷(第1期);第17-23页 *

Also Published As

Publication number Publication date
CN103214489A (zh) 2013-07-24

Similar Documents

Publication Publication Date Title
Liu et al. Design, synthesis and biological evaluation of novel thieno [3, 2-d] pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents
Liu et al. Design, synthesis and biological evaluation of novel thieno [3, 2-d] pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents
Wang et al. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents
EP3567043B1 (en) 2-[[5-[(4-hydroxy-3-chloro-2-methyl)-phenyl]-thieno[2,3-d]pyrimidin-4-yl]oxy]-3-(2-methoxybenzene)propanoic acid derivatives as mcl-1 and bcl-2 inhibitors for treating cancer
CN105622638B (zh) 嘧啶或吡啶并吡啶酮类化合物及其制备方法和应用
Tang et al. Design, synthesis, and structure–activity relationships of novel 6, 7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents
Li et al. Design, Synthesis and Evaluation of Novel Rhodanine‐containing Sorafenib Analogs as Potential Antitumor Agents
Shyma et al. Synthesis, characterization and molecular docking studies of some new 1, 3, 4-oxadiazolines bearing 6-methylpyridine moiety for antimicrobial property
Lawson et al. An efficient coupling of N-tosylhydrazones with 2-halopyridines: synthesis of 2-α-styrylpyridines endowed with antitumor activity
Wang et al. Discovery of novel pyrrolo-pyridine/pyrimidine derivatives bearing pyridazinone moiety as c-Met kinase inhibitors
CN108191874A (zh) 一种C-Kit抑制剂及其应用
Mashayekhi et al. Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones
CN104803925A (zh) 一类以 fgfr 为靶点的 2,4,5-三取代嘧啶类化合物及其制备方法和用途
CN103450176A (zh) 一类含2-（4-氨基苯基）苯并噻唑萘酰亚胺化合物及其应用
CN105017259A (zh) 含有三氟甲基的喹唑啉酮衍生物及其制备方法和应用
Shan et al. Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors
US20160251348A1 (en) PYRIDO[2,3-d]PYRIMIDIN-4-ONE COMPOUNDS AS TANKYRASE INHIBITORS
Zhu et al. Design, synthesis and anticancer activity of 4-morpholinothieno [3, 2-d] pyrimidine derivatives bearing arylmethylene hydrazine moiety
Pan et al. Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1, 2, 3-triazol
Ferreira et al. Synthesis of 2-aroylfuro [3, 2-c] quinolines from quinolone-based chalcones and evaluation of their antioxidant and anticholinesterase activities
CN103214489B (zh) 一类具有抗肿瘤活性的多靶点激酶抑制剂及其制备方法
Li et al. Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl) urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings
JP2019529478A (ja) チロシンキナーゼ阻害剤の結晶形、塩形態及び製造方法
CN107311937A (zh) 一类具抗肿瘤活性的甘草查尔酮a二氢氨基嘧啶类化合物及其合成方法
CN104725319A (zh) 一种具有抗肿瘤活性的1h-吲唑-3-氨基联苯脲类化合物及其制备方法和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20161026

Termination date: 20170225